DrugPatentWatch Database Preview
NATPARA Drug Profile
Summary for Tradename: NATPARA
| Patents: | 993 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NATPARA |
Pharmacology for NATPARA
| Ingredient-type | Parathyroid Hormone |
US Patents for NATPARA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | Purdue Pharma L.P. (Stamford, CT) | 2021-08-06 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | Musculoskeletal Transplant Foundation (Edison, NJ) | 2026-06-27 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | Musculoskeletal Transplant Foundation (Edison, NJ) | 2023-04-29 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | Warner Lambert Company (Morris Plains, NJ) | 2022-04-05 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for NATPARA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 9710994 | Start Trial |
| South Korea | 100372673 | Start Trial |
| China | 105581976 | Start Trial |
| South Korea | 100572171 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for NATPARA
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 300583 | Netherlands | Start Trial | PRODUCT NAME: GLYCOPYRRONIUM EN ALLE DOOR HET BASISOCTROOI BESCHERMDE AFGELEIDEN DAARVAN; REGISTRATION NO/DATE: EU/1/12/788/001-006 20120928 |
| 122005000033 | Germany | Start Trial | PRODUCT NAME: CINACALCET; REGISTRATION NO/DATE: EU/1/04/292/001-012 20041022 |
| SPC/GB05/047 | United Kingdom | Start Trial | PRODUCT NAME: PEGVISOMANT, OPTIONALLY IN THE FORM OF A PEGYLATION VARIANT; REGISTERED: UK EU/1/02/240/001 20021115; UK EU/1/02/240/002 20021115; UK EU/1/02/240/003 20021115 |
| C300467 | Netherlands | Start Trial | PRODUCT NAME: DENOSUMAB; REGISTRATION NO/DATE: EU/1/10/618/001-004 20100526 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
